Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX)
CUSIP: 34962G109
Q3 2020 13F Holders as of 30 Sep 2020
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 20,563,488
- Total 13F shares
- 6,803,921
- Share change
- +3,919,513
- Total reported value
- $330,057,000
- Price per share
- $48.51
- Number of holders
- 45
- Value change
- +$190,204,632
- Number of buys
- 34
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 34962G109?
CUSIP 34962G109 identifies FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 34962G109:
Top shareholders of FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
4.8%
|
978,857
|
$14,272,000 | — | 30 Jun 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
4.6%
|
950,316
|
$13,856,000 | — | 30 Jun 2020 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
3.5%
|
724,144
|
$10,558,000 | — | 30 Jun 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.3%
|
60,740
|
$886,000 | — | 30 Jun 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.24%
|
49,441
|
$721,000 | — | 30 Jun 2020 | |
| MYDA Advisors LLC |
13F
|
Company |
0.19%
|
40,000
|
$583,000 | — | 30 Jun 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
19,450
|
$283,000 | — | 30 Jun 2020 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.09%
|
17,667
|
$258,000 | — | 30 Jun 2020 | |
| LPL Financial LLC |
13F
|
Company |
0.05%
|
10,870
|
$158,000 | — | 30 Jun 2020 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.05%
|
10,200
|
$149,000 | — | 30 Jun 2020 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.05%
|
10,190
|
$149,000 | — | 30 Jun 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
4,025
|
$59,000 | — | 30 Jun 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
3,380
|
$49,000 | — | 30 Jun 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
1,225
|
$18,000 | — | 30 Jun 2020 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.01%
|
1,163
|
$17,000 | — | 30 Jun 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
850
|
$12,000 | — | 30 Jun 2020 | |
| EVOKE WEALTH, LLC |
13F
|
Company |
0%
|
724
|
$11,000 | — | 30 Jun 2020 | |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA |
13F
|
Company |
0%
|
193
|
$3,000 | — | 30 Jun 2020 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
167
|
$2,000 | — | 30 Jun 2020 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
157
|
$2,000 | — | 30 Jun 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
145
|
$2,000 | — | 30 Jun 2020 | |
| CWM, LLC |
13F
|
Company |
0%
|
66
|
$2,000 | — | 30 Jun 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
72
|
$1,000 | — | 30 Jun 2020 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
37
|
$1,000 | — | 30 Jun 2020 |
Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) as of Q3 2020
As of 30 Sep 2020,
Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,803,921 shares.
The largest 10 holders included
ArrowMark Colorado Holdings LLC, FRANKLIN RESOURCES INC, BVF INC/IL, FRED ALGER MANAGEMENT, LLC, CITADEL ADVISORS LLC, ORBIMED ADVISORS LLC, CREDIT SUISSE AG/, VANGUARD GROUP INC, BlackRock Inc., and Asymmetry Capital Management, L.P..
This page lists
45
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
22
Q3 2020 holders
45
Holder diff
23
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 Value $ | Q3 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.